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The incidence rate for Neonatal Abstinence Syndrome (NAS) has seen a 
significant increase in the opioid-exposed newborn population across the 
United States, and research about best clinical prevention and intervention 
methods continues to develop (Ko et al. 2016). According to the CDC, NAS 
prevalence rates in North Carolina increased 2,033% from 0.3 cases per 
1,000 hospital births in 2000 to 6.4 cases per 1,000 births in 2013 (Ko et al. 
2016). NAS can lead to a wide range of symptoms that can impact the central 
nervous system, gastrointestinal system, respiratory system, and autonomic 
nervous system (Brandt & Finnegan, 2017). Symptoms of NAS include 
“irritability, hypertonia, tremors, feeding intolerance, emesis, watery stools, 
seizures, and respiratory distress” (Tsai & Doan, 2016). These infants are 
more likely to have a low birth weight and present with feeding problems 
following birth, requiring intensive medical care (Tsai & Doan, 2016). 
Meconium aspiration syndrome and respiratory distress syndrome are also 
more likely to occur in NAS infants (Patrick, Davis, Lehman, & Cooper, 2015).
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▪ Quality Appraisal= 100%
Exclusion Criteria
•Time: Publish date prior to 01/01/2008
(Research date contained within a ten year period to 
control for medical reviews that would be considered 
traditionally out-of-date. As a majority of our research 
data was found to be within the past decade, this 
temporal limitation will help keep the data current 
with interventions.)
•Types of studies: Peer Reviewed, Case Studies, 
Literature Reviews, Systematic Reviews, 
Questionnaires, Interviews
•Language: Non-English
•Infant age: >1 month
Inclusion Criteria
•Time: Publish date 2008/01/01-2018
•Population: infants born with NAS from mothers 
with only opioid dependence or opioid abuse
•Terminology/Diagnostic Label: "neonatal 
abstinence syndrome" or "neonatal withdrawal 
syndrome" or "neonatal passive addiction" or 
"neonatal substance withdrawal"
•Type of research accepted: RCTs, Controlled 
Experimental, Controlled Observational, 
Uncontrolled Experimental, Uncontrolled 
Observational, Qualitative
•Infant age: Birth - 1 month (*CINAHL does not have 
age restriction search criteria)
•Resource Type: Academic Journals, Peer reviewed
•Language: English Only
This systematic review aims to answer the following question: Does a hybrid 
non-pharmacological/pharmacological intervention in neonates with 
Neonatal Abstinence Syndrome (NAS) differentially impact outcomes when 
compared to traditional pharmacological-only intervention strategies in 
hospital settings?
As this topic is relatively new in the
field of speech-language pathology, 
our research was focused on 
evaluating the effects of the current 
non-pharmacological 
and pharmacological intervention 
methods and observing whether a 
hybrid non-pharmacological and 
pharmacological approach had 
more favorable outcomes when 
compared to the use of 
only pharmacological 
intervention(s).
FIGURE. Neonatal abstinence 
syndrome (NAS) incidence rates — 25 
states, 2012–2013
* NAS cases per 1,000 hospital births
The current epidemic necessitates more research, particularly randomized 
control studies with larger sample sizes, to solidify evidence-based practices 
heavily focused on breastfeeding, mother education, rooming-in practices, 
and other non-pharmacological approaches. There is not enough data on the 
inter-observer reliability of NAS assessment tools, and consequently, more 
research is needed to identify a gold standard NAS assessment tool.  Further, 
additional research is needed to evaluate the health and neurodevelopmental 
outcomes of infants exposed to opioids in utero over time.  A standard care of 
practice for treatment of infants with Neonatal Abstinence Syndrome needs to 
be organized and hospital staff educated on the best possible procedures.
This review has the potential to inform researchers and clinicians seeking a 
gold standard of care for infants with Neonatal Abstinence Syndrome and 
their mothers. The review found several overarching themes in benefits of 
non-pharmacological care for infants with NAS.  All but one of the studies 
found statistically significant benefits of a non-pharmacological intervention, 
specifically rooming-in, breastfeeding, mother education programs, or laser 
acupuncture, on length of hospital stay, need for pharmacological 
management, management of NAS symptoms, and hospital costs. Given the 
current standard of care for NAS, most of the research literature reported use 
of the Finnegan scale to measure the presence and severity of NAS 
symptoms, but several studies suggested the replacement of the Finnegan 
tool with other models, such as the Eat, Sleep, Console model. 
This systematic review is not without limitations—the search only included 
studies published in English and gray literature was not included, so there is 
potential for publication bias. In addition, goals and methodology of the 
studies varied widely, making data synthesis difficult. 
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The data provides further, updated evidence to support the movement towards 
non-pharmacologically based treatment for infants exposed to opioids in utero.  
In particular, evidence supports breastfeeding and removing infants from the 
Neonatal Intensive Care Unit and infant nurseries and keeping them in the 
rooms with their mothers whenever possible. Hospitals that developed 
initiatives to train staff, educate mothers, encourage breastfeeding, and room-
in infants had success in decreasing hospital costs, a reduction in NAS 
symptoms, and a shorter hospital stays.  
